Literature DB >> 9856563

Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.

D R Sumita1, M Vainzof, S Campiotto, A M Cerqueira, M Cánovas, P A Otto, M R Passos-Bueno, M Zatz.   

Abstract

The pattern of X inactivation in lymphocyte DNA was investigated in 107 Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) carriers (102 asymptomatic and 5 manifesting carriers) and 117 normal female controls of different ages, with the aim: a) to analyze the pattern of X inactivation in blood DNA of a large number of DMD/BMD carriers as compared to normal female controls; b) to determine if there is a decrease in serum creatine kinase (CK) levels with age in obligate DMD/BMD carriers; c) to determine if there is a correlation between X-chromosome inactivation and serum CK among asymptomatic DMD/BMD carriers of different ages or with different clinical manifestations in symptomatic carriers. A high proportion of females showed extremely skewed X inactivation (>90% of one X preferentially inactivated), which was almost the same among carriers and normal controls (19 and 24%, respectively). The mean serum CK was significantly greater among young (<20 years old) than adult (>20 years old) DMD/BMD carriers and it decreased significantly until age 20 with an apparent stabilization afterwards. No statistically significant correlation was found between the proportion of active X(DMD) in blood and serum CK activity in DMD/BMD carriers although it was higher among those less than 20 years old. Our observations suggest that highly skewed X-chromosome pattern in blood (with preferential inactivation of the X(N) chromosome) is not enough to predict that a young DMD carrier will develop muscular weakness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856563

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

2.  Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age.

Authors:  Sandra Mercier; Annick Toutain; Aurélie Toussaint; Martine Raynaud; Claire de Barace; Pascale Marcorelles; Laurent Pasquier; Martine Blayau; Caroline Espil; Philippe Parent; Hubert Journel; Leila Lazaro; Jon Andoni Urtizberea; Alexandre Moerman; Laurence Faivre; Bruno Eymard; Kim Maincent; Romain Gherardi; Denys Chaigne; Rabah Ben Yaou; France Leturcq; Jamel Chelly; Isabelle Desguerre
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

3.  Manifesting carriers of X-linked myotubular myopathy: Genetic modifiers modulating the phenotype.

Authors:  Lucas Santos Souza; Camila Freitas Almeida; Guilherme Lopes Yamamoto; Rita de Cássia Mingroni Pavanello; Juliana Gurgel-Giannetti; Silvia Souza da Costa; Isabela Pessa Anequini; Silvana Amanda do Carmo; Jaqueline Yu Ting Wang; Marília de Oliveira Scliar; Erick C Castelli; Paulo Alberto Otto; Edmar Zanoteli; Mariz Vainzof
Journal:  Neurol Genet       Date:  2020-09-04

Review 4.  Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.

Authors:  Emanuela Viggiano; Manuela Ergoli; Esther Picillo; Luisa Politano
Journal:  Hum Genet       Date:  2016-04-21       Impact factor: 4.132

5.  Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype.

Authors:  Simona Brioschi; Francesca Gualandi; Chiara Scotton; Annarita Armaroli; Matteo Bovolenta; Maria S Falzarano; Patrizia Sabatelli; Rita Selvatici; Adele D'Amico; Marika Pane; Giulia Ricci; Gabriele Siciliano; Silvana Tedeschi; Antonella Pini; Liliana Vercelli; Domenico De Grandis; Eugenio Mercuri; Enrico Bertini; Luciano Merlini; Tiziana Mongini; Alessandra Ferlini
Journal:  BMC Med Genet       Date:  2012-08-16       Impact factor: 2.103

6.  Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy.

Authors:  Jonàs Juan-Mateu; Maria José Rodríguez; Andrés Nascimento; Cecilia Jiménez-Mallebrera; Lidia González-Quereda; Eloy Rivas; Carmen Paradas; Marcos Madruga; Pedro Sánchez-Ayaso; Cristina Jou; Laura González-Mera; Francina Munell; Manuel Roig-Quilis; Maria Rabasa; Aurelio Hernández-Lain; Jorge Díaz-Manera; Eduard Gallardo; Jordi Pascual; Edgard Verdura; Jaume Colomer; Montserrat Baiget; Montse Olivé; Pia Gallano
Journal:  Orphanet J Rare Dis       Date:  2012-10-23       Impact factor: 4.123

7.  Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.

Authors:  Sébastien Lévesque; Christiane Auray-Blais; Elaine Gravel; Michel Boutin; Laura Dempsey-Nunez; Pierre-Etienne Jacques; Sébastien Chenier; Sandrine Larue; Marie-France Rioux; Walla Al-Hertani; Amelie Nadeau; Jean Mathieu; Bruno Maranda; Valérie Désilets; Paula J Waters; Joan Keutzer; Stephanie Austin; Priya Kishnani
Journal:  Orphanet J Rare Dis       Date:  2016-01-25       Impact factor: 4.123

8.  Population-Wide Duchenne Muscular Dystrophy Carrier Detection by CK and Molecular Testing.

Authors:  Shuai Han; Hong Xu; Jinxian Zheng; Junhui Sun; Xue Feng; Yue Wang; Wen Ye; Qing Ke; Yanwei Ren; Shulie Yao; Songying Zhang; Jianfen Chen; Robert C Griggs; Zhengyan Zhao; Ming Qi; Michele A Gatheridge
Journal:  Biomed Res Int       Date:  2020-09-27       Impact factor: 3.411

9.  A novel DMD intronic alteration: a potentially disease-causing variant of an intermediate muscular dystrophy phenotype.

Authors:  Ricardo Santin; Igor Araujo Vieira; Jean Costa Nunes; Maria Luiza Benevides; Fernanda Quadros; Ana Carolina Brusius-Facchin; Gabriel Macedo; Ana Paula Santin Bertoni
Journal:  Acta Myol       Date:  2021-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.